Literature DB >> 18805046

Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma.

Lei Zhang1, Xiao Yang, Hong-ya Pan, Xiao-jian Zhou, Jiang Li, Wan-tao Chen, Lai-ping Zhong, Zhi-yuan Zhang.   

Abstract

Previously, we established an in vitro cellular carcinogenesis model of oral squamous cell carcinoma (OSCC) and expression microarray analysis showed that the gene encoding growth differentiation factor 15 (GDF15) was significantly upregulated in this model. In this study, we confirmed that expression of GDF15 was increased both at mRNA and protein levels in a panel of OSCC lines and clinical samples from primary OSCC patients. We also observed that expression of GDF15 was positively correlated with the malignancy of the disease: a higher level of GDF15 expression indicates a higher malignant grade of OSCC. Treatment of OSCC cell line (Tca3118) with siRNA against GDF15 significantly inhibited cellular proliferation and colony formation. Based on these observations, we conclude that GDF15 is a positive gene of OSCC development and progression and GDF15 can be used as an additional marker for histopathologic evaluation of OSCC differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805046     DOI: 10.1016/j.oraloncology.2008.07.017

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  18 in total

1.  Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer.

Authors:  Xiao Tang; Yong-Jie Hu; Wu-Tong Ju; Yong Fu; Wen-Wen Sun; Ying Liu; Yi-Ran Tan; Li-Zhen Wang; Jiang Li; Yao-Yao Tu; Chen-Ping Zhang; Zhi-Yuan Zhang; Lai-Ping Zhong
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

Review 2.  Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

3.  GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways.

Authors:  Naoki Urakawa; Soken Utsunomiya; Mari Nishio; Manabu Shigeoka; Nobuhisa Takase; Noriaki Arai; Yoshihiro Kakeji; Yu-ichiro Koma; Hiroshi Yokozaki
Journal:  Lab Invest       Date:  2015-03-02       Impact factor: 5.662

Review 4.  Concise review: growth differentiation factor 15 in pathology: a clinical role?

Authors:  Jill Corre; Benjamin Hébraud; Philippe Bourin
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

5.  Downregulation of growth differentiation factor-15 in trichostatin A-induced apoptosis could play a role in progression of gastric cancer.

Authors:  Yun-Long Li; Wu Cui; Feng Gao; Zhi-Gang Cao; Xiao-Lin Li; Wen-Xue Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

6.  Prognostic Impact of Serum Growth Differentiation Factor 15 Level in Acute Myeloid Leukemia Patients.

Authors:  Hany Mohamed Hegab; Amro Mohamed Sedky El-Ghammaz; Mostafa Kamal El-Razzaz; Reham Ali Ali Helal
Journal:  Indian J Hematol Blood Transfus       Date:  2020-06-30       Impact factor: 0.900

7.  Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus.

Authors:  Jun Li; Lijun Yang; Weijun Qin; Geng Zhang; Jianlin Yuan; Fuli Wang
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

8.  Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.

Authors:  Xiao-Bing Wang; Xing-Ran Jiang; Xi-Ying Yu; Lin Wang; Shun He; Fei-Yue Feng; Li-Ping Guo; Wei Jiang; Shih-Hsin Lu
Journal:  Cancer Sci       Date:  2014-01-02       Impact factor: 6.716

9.  Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.

Authors:  Yasmin Husaini; Min Ru Qiu; Glen P Lockwood; Xu Wei Luo; Ping Shang; Tamara Kuffner; Vicky Wang-Wei Tsai; Lele Jiang; Pamela J Russell; David A Brown; Samuel N Breit
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

10.  Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.

Authors:  M Mimeault; S L Johansson; S K Batra
Journal:  Br J Cancer       Date:  2013-02-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.